Meet the team
Our team comprises Scientific Group Lead, Dr Marie McIlroy and Clinical Group Lead, Prof. Michael O’Reilly.
Scientific Group Lead, Dr Marie McIlroy has a defined research focus on the potentiating role of androgens in breast cancer development and treatment resistance and has expertise in the augmentation of human endocrine models of disease.
Prof. Michael O’Reilly is an expert in the area of androgen excess, with a specific research focus on androgen-related metabolic dysfunction in women with polycystic ovary syndrome (PCOS).
Core Team
Professor Michael O’Reilly – Clinical Group Lead
Honorary Clinical Associate Professor, RCSI and Consultant Endocrinologist, Beaumont Hospital
Principal Investigator
Dr Marie McIlroy – Scientific Group Lead
Senior Lecturer & Principal Investigator, Department of Surgery, RCSI Scientific Lead for the Endocrine-Related Cancer Programme, Beaumont RCSI Cancer Centre. Dublin.
Principal Investigator
Dr Leanne Cussen
ICAT Fellow and PhD Scholar
Co-Investigator
Dr Tara McDonnell
Clinical Research Fellow and PhD Scholar
Co-Investigator
Dr Clare Miller
StAR MD - RCSI
Co-Investigator
Stephanie Agbana MSc
PhD Scholar, RCSI (2022-2026)
Co-Investigator
Jingqi Xin MSc
RCSI StAR PhD Programme Scholar
Co-Investigator
Collaborators
Professor Wiebke Arlt
William Withering Chair of Medicine Director of the Institute of Metabolism and Systems Research University of Birmingham
Collaborator
Professor Dario Alessi
Professor of Signal Transduction Director of MRC Protein Phosphorylation and Ubiquitylation Unit (MRC-PPU) and the Division of Signal Transduction Therapy Unit (DSTT)
Collaborator
Professor Jeremy Tomlinson
Professional Fellow, University of Oxford
Collaborator
Professor Pavel Soucek
Head, Laboratory of Pharmacogenomics, Biomedical Center, Charles University, Czechia
Collaborator
Dr Stephen Madden
Lecturer, RCSI
Collaborator
Ms Maureen Busby
CEO & Founder, PCOS Vitality
Collaborator